-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
-
Trump in Epstein files: five takeaways from latest release
-
Wasteful Nigeria open AFCON campaign with narrow win over Tanzania
-
Ukraine retreats in east as Russian strikes kill three, hit energy
-
Macron meets French farmers in bid to defuse anger over trade deal
-
Ineos snap up Scotsman Onley
-
UK comedian Russell Brand faces new rape, assault charges: police
-
World is 'ready' for a woman at helm of UN: Chile's Bachelet tells AFP
-
Real Madrid's Endrick joins Lyon on loan
-
Latest Epstein files renew scrutiny of Britain's ex-prince Andrew
-
US consumer confidence tumbles in December
-
Norwegian biathlete Sivert Guttorm Bakken found dead in hotel
-
UK comedian Russell Brand faces two new rape, assault charges: police
-
Venezuela seeks to jail backers of US oil blockade
-
Norwegian biathlete Sivert Guttorm Bakken found dead
-
Wall Street stocks edge higher
-
Vietnam Communist Party endorses To Lam to stay in top job
-
US economic growth surges in 3rd quarter, highest rate in two years
-
Frank defends Van de Ven after Slot slams 'reckless' foul on Isak
-
Russian paramilitaries in CAR say take election threat 'extremely seriously'
-
Trump in the Epstein files: five takeaways from latest release
-
UK govt to relax farmers inheritance tax after protests
-
Pakistani firm wins auction for state airline PIA
-
Stocks slip on strong US growth data
-
DR Congo beat Benin to kick off Cup of Nations bid
-
New Epstein files dump contains multiple Trump references
-
Russian strike could collapse Chernobyl shelter: plant director
-
Springbok captain Kolisi to rejoin Stormers
-
Italy fines Ryanair $300 mn for abuse of dominant position
-
Mahrez eyes strong AFCON showing from Algeria
-
Killer in Croatia school attack gets maximum 50-year sentence
-
Thousands of new Epstein-linked documents released by US Justice Dept
-
Stocks steady as rate cut hopes bring Christmas cheer
-
Bangladesh summons Indian envoy as protest erupts in New Delhi
-
Liverpool's Isak faces two months out after 'reckless' tackle: Slot
-
Thailand-Cambodia border meeting in doubt over venue row
-
For director Josh Safdie, 'Marty Supreme' and Timothee Chalamet are one and the same
-
Kyiv's wartime Christmas showcases city's 'split' reality
-
Gazans fear renewed displacement after Israeli strikes
-
Locals sound alarm as Bijagos Islands slowly swallowed by sea
-
Markets mostly rise as rate cut hopes bring Christmas cheer
Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies
TAMPA, FLORIDA / ACCESS Newswire / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.
The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.
Pharmacies can now enroll in the beta program at:
https://wellgisticshealth.com/xrp-in-healthcare/
How Pharmacies Benefit from Using XRP
Instant Settlement - Payments settle in seconds, not days
Lower Fees - Avoid credit card and bank transaction costs
24/7 Availability - No banking delays, even on weekends and holidays
Improved Cash Flow - Faster access to working capital and inventory restock
Real-Time Tracking - View and confirm payments instantly
No Intermediaries - Direct transactions between pharmacy and distributor
"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."
Technical Innovation and Blockchain Integration
The XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.
Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:
https://wellgisticshealth.com/xrp-in-healthcare/
Regulatory Compliance and Security
The XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.
Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) Programs
Following the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance.
"Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."
About Wellgistics Health
Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.
About RxERP
RxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.
Forward-Looking Statements
This press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.
Media Contact: [email protected]
Investor Relations: [email protected]
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
G.P.Martin--AT